Back to Search Start Over

Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference.

Authors :
Jiang, W.-Q.
Zhong, Z.-H.
Henson, J. D.
Reddel, R. R.
Source :
Oncogene; 7/12/2007, Vol. 26 Issue 32, p4635-4647, 13p, 7 Diagrams, 1 Chart
Publication Year :
2007

Abstract

Telomerase-negative cancer cells can maintain their telomeres by a recombination-mediated alternative lengthening of telomeres (ALT) process. We reported previously that sequestration of MRE11/RAD50/NBS1 complexes represses ALT-mediated telomere length maintenance, and suppresses formation of ALT-associated promyelocytic leukemia (PML) bodies (APBs). APBs are PML bodies containing telomeric DNA and telomere-binding proteins, and are observed only in a small fraction of cells within asynchronously dividing ALT-positive cell populations. Here, we report that methionine restriction caused a reversible arrest in G<subscript>0</subscript>/G<subscript>1</subscript> phase of the cell cycle and reversible induction of APB formation in most cells within an ALT-positive population. We combined methionine restriction with RNA interference to test whether the following proteins are required for APB formation: PML body-associated proteins, PML and Sp100; telomere-associated proteins, TRF1, TRF2, TIN2 and RAP1; and DNA repair proteins, MRE11, RAD50, NBS1 and 53BP1. APB formation was not decreased by depletion of Sp100 (as reported previously) or of 53BP1, although 53BP1 partially colocalizes with APBs. Depletion of the other proteins suppressed APB formation. Because of the close linkage between ALT-mediated telomere maintenance and ability to form APBs, the eight proteins identified by this screen as being required for APB formation are also likely to be required for the ALT mechanism.Oncogene (2007) 26, 4635–4647; doi:10.1038/sj.onc.1210260; published online 5 February 2007 [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09509232
Volume :
26
Issue :
32
Database :
Complementary Index
Journal :
Oncogene
Publication Type :
Academic Journal
Accession number :
25707821
Full Text :
https://doi.org/10.1038/sj.onc.1210260